Aeglea Biotherapeutics shares owned by Bank of America Corporation
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Bank of America Corporation
from 13F filings
Historical chart of Bank of America Corporation investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Aeglea Biotherapeutics by Bank of America Corporation
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $166k | 7.1k | 23.28 |
2024-09-30 | $7.6M | 258k | 29.41 |
2024-06-30 | $4.5M | 191k | 23.51 |
2024-03-31 | $1.4M | 36k | 37.93 |
More positions owned by Bank of America Corporation
View all positions for Bank of America Corporation